What is the official ID of this bill?

The official print number for this legislation is HR 6875.

When did the legislative process begin?

The process officially started on 2022-02-28.

Where can I read the full text of this legislation?

The full official text is available at: https://www.congress.gov/117/bills/hr6875/BILLS-117hr6875ih.htm

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

Who is the primary sponsor?

The primary sponsor is Rep. Swalwell, Eric [D-CA-15].

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Analysis and Potential Impact of HR 6875

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

Safer Medications: Better Dosing and Fewer Side Effects

Q: What are the main provisions?

Key points include: Public Education: Increasing awareness about drug risks and the benefits of pharmacogenomic testing, which helps select appropriate medications and dosages. Improved Medical Systems: Changes to electronic health records to give doctors easier access to patient genetic information, helping avoid dangerous drug interactions. Support for Healthcare Providers: Educational programs for healthcare professionals to better understand and utilize pharmacogenomic testing in treatment. Reduced Side Effects: Initiatives to lower the number of adverse reactions to common medications like anticoagulants, hypoglycemic agents, and opioid analgesics.

This act aims to reduce adverse drug reactions through education, improved medical systems, and research. Citizens can expect safer treatment, better tailored to their individual genetic needs, reducing the risk of complications and hospital visits.

Key points

Public Education: Increasing awareness about drug risks and the benefits of pharmacogenomic testing, which helps select appropriate medications and dosages.

Improved Medical Systems: Changes to electronic health records to give doctors easier access to patient genetic information, helping avoid dangerous drug interactions.

Support for Healthcare Providers: Educational programs for healthcare professionals to better understand and utilize pharmacogenomic testing in treatment.

Reduced Side Effects: Initiatives to lower the number of adverse reactions to common medications like anticoagulants, hypoglycemic agents, and opioid analgesics.

article Official text account_balance Process page notifications_active Track this Bill

gavel

Status:

Expired

Record your position for audit.

Why does your vote on bills matter?

It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.

Additional Information

Right Drug Dose Now Act

Print number: HR 6875

Sponsor: Rep. Swalwell, Eric [D-CA-15]

Process start date: 2022-02-28

System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.

Summarized by: gemini-2.5-flash-preview-05-20

Source data: api.congress.gov

AI work logs for this document launch

Safer Medications: Better Dosing and Fewer Side Effects

Key Questions about Safer Medications: Better Dosing and Fewer Side Effects